1. 94PHPV circulating tumor DNA as predictive biomarker of sustained response to chemotherapy in advanced anal carcinoma. (23rd October 2018) Authors: Bernard-Tessier, A; Jeannot, E; Guenat, D; Michel, M; Proudhon, C; Vincent-Salomon, A; Bièche, I; Pierga, J-Y; Buecher, B; Francois, E; Kim, S; André, T; Jary, M; Vendrely, V; Samalin, E; El Hajbi, F; Baba-Hamed, N; Meurisse, A; Bidard, F-C; Borg, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating tumor DNA detection in hepatocellular carcinoma. (4th April 2018) Authors: Cabel, L; Proudhon, C; Buecher, B; Pierga, J -Y; Bidard, F -C Journal: Annals of oncology Issue: Volume 29:Number 5(2018) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial. (11th June 2018) Authors: Ignatiadis, M; Litière, S; Rothe, F; Riethdorf, S; Proudhon, C; Fehm, T; Aalders, K; Forstbauer, H; Fasching, P A; Brain, E; Vuylsteke, P; Guardiola, E; Lorenz, R; Pantel, K; Tryfonidis, K; Janni, W; Piccart, M; Sotiriou, C; Rack, B; Pierga, J -Y Journal: Annals of oncology Issue: Volume 29:Number 8(2018) Page Start: 1777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗